Dynavax Technologies (DVAX) EPS (Weighted Average and Diluted): 2019-2025
Historic EPS (Weighted Average and Diluted) for Dynavax Technologies (DVAX) over the last 7 years, with Sep 2025 value amounting to $0.21.
- Dynavax Technologies' EPS (Weighted Average and Diluted) rose 75.00% to $0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.37, marking a year-over-year decrease of 380.94%. This contributed to the annual value of $0.20 for FY2024, which is 500.00% up from last year.
- Latest data reveals that Dynavax Technologies reported EPS (Weighted Average and Diluted) of $0.21 as of Q3 2025, which was up 50.00% from $0.14 recorded in Q2 2025.
- In the past 5 years, Dynavax Technologies' EPS (Weighted Average and Diluted) ranged from a high of $0.87 in Q2 2022 and a low of -$0.77 during Q1 2025.
- Over the past 3 years, Dynavax Technologies' median EPS (Weighted Average and Diluted) value was $0.05 (recorded in 2024), while the average stood at -$0.03.
- In the last 5 years, Dynavax Technologies' EPS (Weighted Average and Diluted) skyrocketed by 4,250.00% in 2022 and then plummeted by 1,000.00% in 2025.
- Dynavax Technologies' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.77 in 2021, then slumped by 40.26% to $0.46 in 2022, then tumbled by 99.63% to $0.00 in 2023, then soared by 2,839.11% to $0.05 in 2024, then soared by 75.00% to $0.21 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.21 in Q3 2025, compared to $0.14 in Q2 2025 and -$0.77 in Q1 2025.